{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:10:51Z","timestamp":1759342251571},"reference-count":106,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.2217\/imt.09.59","type":"journal-article","created":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T13:05:48Z","timestamp":1257253548000},"page":"1053-1061","source":"Crossref","is-referenced-by-count":14,"title":["Prevention of Hepatitis B Virus Reactivation Under Rituximab Therapy"],"prefix":"10.1080","volume":"1","author":[{"given":"Yutaka","family":"Tsutsumi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hakodate Municipal Hospital 1\u201310\u20131, Minato-cho, Hakodate041\u20138680, Japan. Tel.: + Fax: +"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Gastroenterology, Hakodate Municipal Hospital, Hakodate, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Hematology &amp; Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Asaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Imamura","sequence":"additional","affiliation":[{"name":"Hematology &amp; Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Masauzi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hakodate Municipal Hospital 1\u201310\u20131, Minato-cho, Hakodate041\u20138680, Japan. Tel.: + Fax: +"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,11,3]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.8.2457.2457"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2188"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.10.3266"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2825"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008265313133"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02981940"},{"key":"e_1_3_2_3_7_1","first-page":"1927","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter Phase II study.","volume":"92","author":"Coiffer B","year":"1998","unstructured":"Coiffer B , HaiounN, EngertKA et al.: Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter Phase II study.Blood92 , 1927\u20131932 (1998).","journal-title":"Blood"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.2.317"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.6.1851"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008301432453"},{"key":"e_1_3_2_3_11_1","first-page":"53","article-title":"Optimizing the use of rituximab for treatment of B-cell non-Hodgkin\u2018s lymphoma:a benefit\u2013risk update.","volume":"27","author":"Kunkel L","year":"2000","unstructured":"Kunkel L , WongA, ManeatisT et al.: Optimizing the use of rituximab for treatment of B-cell non-Hodgkin\u2018s lymphoma:a benefit\u2013risk update.Semin. Oncol.27 , 53\u201361 (2000).","journal-title":"Semin. Oncol."},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02982806"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf155"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh176"},{"key":"e_1_3_2_3_15_1","first-page":"875","article-title":"Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin\u2018s lymphoma.","volume":"89","author":"Rothe A","year":"2004","unstructured":"Rothe A , SchulzH, ElterT, EngertA, ReiserM: Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin\u2018s lymphoma.Haematologica89 , 875\u2013876 (2004).","journal-title":"Haematologica"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2003.12.007"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.04.020"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_3_2_3_19_1","first-page":"894","article-title":"Fatal visceral varicella\u2013zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.","volume":"85","author":"Bermudez A","year":"2000","unstructured":"Bermudez A , MarcoF, CondeE, MazoE, RecioM, ZubizarretaA: Fatal visceral varicella\u2013zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.Haematologica85 , 894\u2013895 (2000).","journal-title":"Haematologica"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.3.1184.015k54_1184_1186"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200109273451315"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.4.1486"},{"key":"e_1_3_2_3_23_1","first-page":"538","article-title":"Fulminating hepatic failure in leukemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.","volume":"2","author":"Galbraith RM","year":"1975","unstructured":"Galbraith RM , EddlestonAL, WilliamsR, ZuckermanAJ, BagshaweKD: Fulminating hepatic failure in leukemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.Lancet2 , 538\u2013530 (1975).","journal-title":"Lancet"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-4-447"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1985.00360070195034"},{"key":"e_1_3_2_3_26_1","first-page":"911","article-title":"Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients.","volume":"73","author":"Lau JY","year":"1989","unstructured":"Lau JY , LaiCL, LinHJ et al.: Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients.Quart. J. Med.73 , 911\u2013917 (1989).","journal-title":"Quart. J. Med."},{"key":"e_1_3_2_3_27_1","first-page":"895","article-title":"Acute liver decompensation of withdrawal of cytotoxic and immunosuppressive therapy in hepatitis B carriers.","volume":"73","author":"Bird GL","year":"1989","unstructured":"Bird GL , SmithH, PortmannB, AlexanderGJ, WilliamsR: Acute liver decompensation of withdrawal of cytotoxic and immunosuppressive therapy in hepatitis B carriers.Quart. J. Med.73 , 895\u2013902 (1989).","journal-title":"Quart. J. Med."},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900080504"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114681"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90599-G"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900215)65:4<878::AID-CNCR2820650409>3.0.CO;2-K"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90513-2"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/8.suppl_1.S107"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.3.599"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0585-6"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.268"},{"issue":"6","key":"e_1_3_2_3_39_1","first-page":"ECR22","volume":"88","author":"Hernandez JA","year":"2003","unstructured":"Hernandez JA , DiloyR, SalatD, del Rio N, Martinez X, Castellvi JM: Fluminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab. Haematologica88(6) , ECR22 (2003).","journal-title":"Haematologica"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402567"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1403"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770100346"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.01692.x"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440120"},{"key":"e_1_3_2_3_45_1","first-page":"0827","article-title":"\u2018Standard dose\u2018 rituximab in refractory chronic lymphocytic leukemia.","volume":"3","author":"Rossini F","year":"2002","unstructured":"Rossini F , CapalboS, FumagalliM et al.: \u2018Standard dose\u2018 rituximab in refractory chronic lymphocytic leukemia.Hematol. J.3(Suppl. 1) , 0827 (2002).","journal-title":"Hematol. J."},{"key":"e_1_3_2_3_46_1","first-page":"1229","volume":"87","author":"Domingo-Domenech E","year":"2002","unstructured":"Domingo-Domenech E , Gonzalez-BarcaE, EstanyC, SuredaA, BesalduchJ, de Sevilla AF: Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas. Haematologica87 , 1229\u20131230 (2002).","journal-title":"Haematologica"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000151923"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-003-0748-4"},{"key":"e_1_3_2_3_49_1","first-page":"483","article-title":"Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine\/cyclophosphamide\/rituximab for low grade non-Hodgkin\u2018s lympohma.","volume":"13","author":"Wasmuth JC","year":"2008","unstructured":"Wasmuth JC , FischerHP, SauerbruchT, DumoulinFL: Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine\/cyclophosphamide\/rituximab for low grade non-Hodgkin\u2018s lympohma.Eur. J. Med. Res.13 , 483\u2013486 (2008).","journal-title":"Eur. J. Med. Res."},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1590"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.0158"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0396-1"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5415.825"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.19324"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1082604"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5424.107"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.9.5208"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.24839"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(02)00773-8"},{"key":"e_1_3_2_3_60_1","first-page":"1627","article-title":"Steroid free chemotherapy decrease the risk of hepatitis flare ups in hepatitis B virus carriers with nonHodgkin\u2018s lymphoma.","volume":"87","author":"Chen AL","year":"1996","unstructured":"Chen AL : Steroid free chemotherapy decrease the risk of hepatitis flare ups in hepatitis B virus carriers with nonHodgkin\u2018s lymphoma.Blood87 , 1627\u20131631 (1996).","journal-title":"Blood"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.0182"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601699"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-7-200804010-00008"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357900600815232"},{"key":"e_1_3_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.09.026"},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050510"},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01847.x"},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.2.391"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.040675"},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200396"},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190801975568"},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200307000-00017"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2004.0964.x"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki114"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21024"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21701"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-0725-1"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1159\/000046631"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10043"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200243"},{"key":"e_1_3_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0454-3"},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20110"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.29401"},{"key":"e_1_3_2_3_84_1","first-page":"1296","article-title":"Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin\u2018s lymphomas: high prevalence of acquired viral genomic mutations.","volume":"88","author":"Picardi M","year":"2003","unstructured":"Picardi M , PaneF, QuintarelliC et al.: Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin\u2018s lymphomas: high prevalence of acquired viral genomic mutations.Haematologica88 , 1296\u20131303 (2003).","journal-title":"Haematologica"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21311"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21513"},{"key":"e_1_3_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.015"},{"key":"e_1_3_2_3_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01134.x"},{"key":"e_1_3_2_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.10.001"},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00344.x"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh430"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.10.006"},{"key":"e_1_3_2_3_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000151661.52601.FB"},{"key":"e_1_3_2_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2003.11.007"},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-163493"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0899-y"},{"key":"e_1_3_2_3_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21214"},{"key":"e_1_3_2_3_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07451.x"},{"key":"e_1_3_2_3_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2008.00936.x"},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21051"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70264-5"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.037"},{"key":"e_1_3_2_3_103_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.051"},{"key":"e_1_3_2_3_104_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200501203520324"},{"key":"e_1_3_2_3_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00364-7"},{"key":"e_1_3_2_3_106_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1954"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.09.59","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:42:28Z","timestamp":1715949748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.09.59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.2217\/imt.09.59"],"URL":"https:\/\/doi.org\/10.2217\/imt.09.59","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}